Should You Buy, Sell or Hold Pfizer Stock Before Q3 Earnings?
PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the third quarter.
| Ticker |
Sentiment |
Impact |
|
LLY
|
Neutral
|
8 %
|
|
ABBV
|
Neutral
|
4 %
|
|
AZN
|
Neutral
|
8 %
|
|
NVO
|
Neutral
|
8 %
|
|
PFE
|
Somewhat Bullish
|
44 %
|
|
BNTX
|
Neutral
|
4 %
|
